Abstract:Microglia play an important role in neurodegenerative disease [i.e., Parkinson's disease (PD), Alzheimer's disease (AD), and amyotrophic lateral sclerosis (ALS)]. These diseases share some similar pathological changes and several microglia-associated processes, including immune response, neuroinflammation, phagocytosis, elimination of synapses et al. Microglia in the central nervous system (CNS) has been described as having both destructive and protective effects in neurological disorders. Besides, considerable evidence also indicates that microglia play a significant role in neurogenesis, neuronal cell death, and synaptic interactions. The communication between microglia and neurons is of vital role in regulating complex functions which are key to appropriate the activity of the brain. Accumulating studies have also demonstrated that exosomes with sizes ranging from 40-100 nm, released by microglia, could serve as key mediators in intercellular signaling. These exosomes, identified in terms of cellular origin in many kinds of biological fluids, exert their effects by delivering specific cargos such as proteins, microRNAs (miRNAs), and mRNAs. It was shown that microglial exosomes could transport to and be uptake by neurons, which may either be beneficial or instead, detrimental to CNS diseases. The focus of this review is to summarize the involvement of microglial exosomes in critical pathologies associated with neurodegenerative disease and how they contribute to these disorders, including PD, AD, and ALS. We also review the application of microglia exosomes as potential biomarkers in monitoring disease progression, as well as focusing on their roles as drug delivery vehicles in treating neurodegenerative disorders.

Endolysosomal dysfunction and exosome secretion: implications for neurodegenerative disorders

Neuronal lysosomal dysfunction releases exosomes harboring APP C-terminal fragments and unique lipid signatures

Impact of endolysosomal dysfunction upon exosomes in neurodegenerative diseases

Endo-lysosomal dysfunction in neurodegenerative diseases: opinion on current progress and future direction in the use of exosomes as biomarkers

Endosomal dysfunction impacts extracellular vesicle release: Central role in Aβ pathology

Endosomal-lysosomal dysfunction in metabolic diseases and Alzheimer's disease

Dysfunctional Autophagy and Endolysosomal System in Neurodegenerative Diseases: Relevance and Therapeutic Options

Exosomes, an Unmasked Culprit in Neurodegenerative Diseases

Endosome function and dysfunction in Alzheimer's disease and other neurodegenerative diseases

Microglial Exosomes in Neurodegenerative Disease

Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship?

Transmissible Endosomal Intoxication: A Balance between Exosomes and Lysosomes at the Basis of Intercellular Amyloid Propagation

Shared and distinct changes in the molecular cargo of extracellular vesicles in different neurodegenerative diseases

Focus on Extracellular Vesicles: Exosomes and Their Role in Protein Trafficking and Biomarker Potential in Alzheimer’s and Parkinson’s Disease

The endosomal-lysosomal system: from acidification and cargo sorting to neurodegeneration

Exosomal Proteins And Mirnas As Mediators Of Amyotrophic Lateral Sclerosis

Accumulation of APP C-terminal fragments causes endolysosomal dysfunction through the dysregulation of late endosome to lysosome-ER contact sites

Amyloid Precursor Protein-Mediated Endocytic Pathway Disruption Induces Axonal Dysfunction and Neurodegeneration.

The role of exosomes in the pathogenesis of Alzheimer’ disease

The interplay between aging-associated loss of protein homeostasis and extracellular vesicles in neurodegeneration

Altered lysosomal proteins in neural-derived plasma exosomes in preclinical Alzheimer disease